Jonathan Shamash

Charterhouse Square
London, ENG EC1M6BQ, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 84 publications

High Frequency Loss of 17q11.2 and Downregulation of the Cancer Metastasis Suppression microRNA miR-193a-3p in Prostate Cancer Bone Metastasis.

High Frequency Loss of 17q11.2 and Downregulation of the Cancer Metastasis Suppression microRNA miR-193a-3p in Prostate Cancer Bone Metastasis.

Journal: Cancers
Published: January 04, 2026

Clinical Outcomes of the Alternative GAMMA Regimen in Relapsed Germ Cell Tumours.

Clinical Outcomes of the Alternative GAMMA Regimen in Relapsed Germ Cell Tumours.

Journal: Cancer medicine
Published: November 17, 2025

Systematic Review and Meta-Analysis of the Management of Relapsed Germ Cell Tumours Following Cisplatin-Based Chemotherapy.

Systematic Review and Meta-Analysis of the Management of Relapsed Germ Cell Tumours Following Cisplatin-Based Chemotherapy.

Journal: Oncology and therapy
Published: September 12, 2025

Treatment Strategies in Metastatic Castration-Resistant Prostate Cancer: A Narrative Review of Considerations in the Post-ARTA, Post-Docetaxel Setting.

Treatment Strategies in Metastatic Castration-Resistant Prostate Cancer: A Narrative Review of Considerations in the Post-ARTA, Post-Docetaxel Setting.

Journal: Oncology and therapy
Published: September 11, 2025

GAMMA: Results from a Phase II Study for Relapsed Germ Cell Tumors using an Oxaliplatin-Based Treatment Regimen.

GAMMA: Results from a Phase II Study for Relapsed Germ Cell Tumors using an Oxaliplatin-Based Treatment Regimen.

Journal: Clinical genitourinary cancer
Published: July 20, 2025

Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours.

Therapy de-escalation for testicular cancer (THERATEST): A multi-centre observational cohort feasibility study of de-escalation therapies for good prognosis stage II germ cell tumours.

Journal: BJUI compass
Published: June 22, 2025

Treatment de-escalation for metastatic good-risk seminoma with carboplatin AUC10: predictive factors and patterns of relapse.

Treatment de-escalation for metastatic good-risk seminoma with carboplatin AUC10: predictive factors and patterns of relapse.

Journal: Therapeutic advances in medical oncology
Published: April 02, 2025

A Phase II, Single Arm, Multicentre Trial of Triamcinolone With a GnRH Analog for Castrate-Resistant Prostate Cancer (TRICREST).

A Phase II, Single Arm, Multicentre Trial of Triamcinolone With a GnRH Analog for Castrate-Resistant Prostate Cancer (TRICREST).

Journal: The Prostate
Published: November 29, 2024

Robotic-assisted retroperitoneal lymph node dissection: defining selection parameters-a B-SAFE approach.

Robotic-assisted retroperitoneal lymph node dissection: defining selection parameters-a B-SAFE approach.

Journal: Journal of robotic surgery
Published: November 20, 2024

Management of Small Testicular Masses: A Delphi Consensus Study.

Management of Small Testicular Masses: A Delphi Consensus Study.

Journal: European urology oncology
Published: September 19, 2024

Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards.

Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards.

Journal: Nature reviews. Urology
Published: September 10, 2024

Prostate Cancer Survivorship and Global Health-Related Quality of Life.

Prostate Cancer Survivorship and Global Health-Related Quality of Life.

Journal: JCO oncology practice
Published: April 16, 2024
Showing 1-12 of 84

Last Updated: 09/26/2026